| PERIOD ENDING | 27-Sep-08 | 28-Jun-08 | 29-Mar-08 | 29-Dec-07 | | Total Revenue | 3,349,000 | 3,507,000 | 3,083,000 | 3,491,000 | | Cost of Revenue | 2,109,000 | 2,157,000 | 1,891,000 | 2,165,000 | | | Gross Profit | 1,240,000 | 1,350,000 | 1,192,000 | 1,326,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,041,000 | 967,000 | 964,000 | 1,086,000 | | Non Recurring | (154,000) | 889,000 | (11,000) | 7,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 353,000 | (506,000) | 239,000 | 233,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21,000 | 21,000 | 20,000 | 21,000 | | Earnings Before Interest And Taxes | 374,000 | (485,000) | 259,000 | 254,000 | | Interest Expense | 46,000 | 44,000 | 39,000 | 50,000 | | Income Before Tax | 328,000 | (529,000) | 220,000 | 204,000 | | Income Tax Expense | 98,000 | 128,000 | (14,000) | 22,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 230,000 | (657,000) | 234,000 | 182,000 | | | Non-recurring Events | | Discontinued Operations |
-
| (15,000) | (23,000) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 230,000 | (672,000) | 211,000 | 182,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $230,000 | ($672,000) | $211,000 | $182,000 |
|
3.31% Nasdaq 
Income Statement
